Enlivex Therapeutics Ltd.
ENLV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $1 | $48 | $11 |
| Short-Term Investments | $20 | $27 | $0 | $73 |
| Receivables | $1 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $1 | -$12 |
| Other Curr. Assets | $1 | $6 | $1 | $2 |
| Total Curr. Assets | $26 | $34 | $52 | $86 |
| Property Plant & Equip (Net) | $1 | $3 | $15 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $15 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $28 | $37 | $68 | $95 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $5 | $4 | $3 |
| Total Curr. Liab. | $4 | $6 | $7 | $5 |
| LT Debt | $0 | $1 | $4 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $1 | $4 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $5 | $6 |
| Total Liabilities | $4 | $7 | $11 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $2 | $2 | $2 |
| Retained Earnings | -$127 | -$112 | -$83 | -$52 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $147 | $139 | $137 | $134 |
| Total Equity | $24 | $30 | $57 | $85 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $28 | $37 | $68 | $95 |
| Net Debt | -$3 | $0 | -$43 | -$5 |